Award
National Institute of Arthritis and Musculoskeletal and Skin Diseases 5K23AR085799-02
Assessing Risk for Poor Outcomes in Antiphospholipid Syndrome
Recipient
Hospital for Special Surgery
Award Amount
$175,373.00
Ceiling
$175,373.00
Awarded
July 03, 2026
Identifier
5K23AR085799-02
NIH grant awarded to develop and validate methods for identifying APS patients and predicting poor outcomes using bioinformatics and biomarkers, aiming to improve risk stratification and treatment.
Description
This project aims to develop and validate methods to identify antiphospholipid syndrome (APS) in large cohorts, evaluate its utility in predicting poor outcomes, and identify subphenotypes based on longitudinal data. It employs novel bioinformatics and biomarker-related approaches to accurately identify APS patients in large multi-center electronic health record cohorts and subphenotype patients based on risk of APS outcomes, leading to improved risk stratification and treatment strategies.